Development of novel Mu opioid receptor antagonists based on a 6,4-spiro bicyclic fentanyl-derived scaffold.
Scaffold reorganization represents a strategy for modulating Mu opioid receptor (MOR) signaling within flexible opioid scaffolds. Herein, a 6,4-spiro bicyclic core derived from the fentanyl framework was adopted to reduce conformational flexibility while preserving key pharmacophoric features of the parent 8-membered scaffold. Biological evaluations identified compound 3, bearing 2-furanyl and cyclobutylmethyl substituents, as the most potent analogue in this series. Compound 3 exhibited MOR bin...